11 completed, 3 unknown, 2 active not recruiting, 2 not yet recruiting. 8 Phase 2, 6 Phase 1, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 5, Active not recruiting 2, Not yet recruiting 1 |
| Phase 1 | 6 | Completed 4, Active not recruiting 1, Not yet recruiting 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Pancytopenia: new trials by email Literature Review of Pancytopenia trials Research Report on Pancytopenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical, Hematological and Pathological Profile of Pancytopenia Pancytopenia | Not yet recruiting | Assiut University | 140 | 2026-08-01 | 2026-08-25 | |
| A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes Dibotatug (DR-01) - Bone Marrow Failure Syndromes, Aplastic Anemias | Phase 1 / Phase 2 | Not yet recruiting | Dren Bio | 60 | 2026-08-01 | 2026-07-24 |
| Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform Shwachman-Diamond Syndrome, SDS | Recruiting | Shwachman-Diamond Syndrome Alliance Inc | 8000 | 2024-02-07 | 2025-05-31 | |
| Spectrum of Hematological Disorders in Pediatrics CBC.with with differential Peripheral smear - Pancytopenia | Unknown | Assiut University | 100 | 2022-09-01 | 2022-07-26 | |
| Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study) whole genome and transcriptome sequencing - Inherited BMF Syndrome, Inherited Platelet Disorder | Recruiting | Peter MacCallum Cancer Centre, Australia | 350 | 2022-03-18 | 2024-11-07 | |
| Eltrombopag for Fanconi Anemia Eltrombopag - Fanconi Anemia | Phase 2 | Active not recruiting | National Heart, Lung, and Blood Institute (NHLBI) | 25 | 2018-11-02 | 2026-09-16 |
| Management of Childhood Pancytopenia Complete blood picture - Pancytopenia | Unknown | Assiut University | 25 | 2018-06-01 | 2018-05-11 | |
| Severe Immune Cytopenia Registry Www.Sic-reg.Org potential biomarkers - Immune Thrombocytopenia, Autoimmune Hemolytic Anemia | Completed | Medical University of Graz | 80 | 2018-03-09 | 2025-11-21 | |
| Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects Eltrombopag, Rabbit ATG, CsA - Aplastic Anemia | Phase 2 | Completed | Novartis Pharmaceuticals | 10 | 2015-05-12 | 2019-07-26 |
| A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia Eltrombopag 12.5 mg, Eltrombopag 25 mg - Cytopaenia | Phase 2 | Completed | Novartis Pharmaceuticals | 21 | 2014-07-23 | 2019-05-03 |
| Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia ATG-fresenius - Aplastic Anemia | Not applicable | Unknown | National Institute of Blood Disease Center, Pakistan | 60 | 2013-09-01 | 2016-04-05 |
| Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia Cohort 1: hATG, CsA, EPAG Day 14 to Month 6, Cohort 2: hATG, CsA, EPAG Day 14 to Month 3, Cohort 3: hATG, CsA (dose reduced), EPAG day 1 to month 6 - Severe Aplastic Anemia | Phase 1 / Phase 2 | Active not recruiting | National Heart, Lung, and Blood Institute (NHLBI) | 207 | 2012-07-02 | 2026-04-13 |
| Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia Cyclophosphamide, Cyclosporine - Aplastic Anemia, Neutropenia | Phase 1 / Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 22 | 2010-08-01 | 2017-05-22 |
| A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia Cyclophosphamide, Fludarabine - Aplastic Anemia, Neutropenia | Phase 1 / Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1 | 2010-08-01 | 2021-07-02 |
| Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia Anti-thymocyte globulin (rabbit), Anti-thymocyte globulin (horse), Cyclosporine - Immunosuppresion, Thrombocytopenia | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 136 | 2005-11-28 | 2017-06-08 |
| Oral Manifestations of Aplastic Anemia Aplastic Anemia | Completed | National Institute of Dental and Craniofacial Research (NIDCR) | 146 | 2000-04-01 | 2008-03-04 | |
| Gene Therapy for the Treatment of Fanconi's Anemia Type C Transduced CD34+ Cells - Fanconi's Anemia, Pancytopenia | Phase 1 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 9 | 1993-12-03 | 2017-07-02 |
| Stem Cell Factor Medication for Aplastic Anemia Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF) - Aplastic Anemia, Pancytopenia | Phase 1 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 40 | 1993-10-01 | 2008-03-04 |
| Collection of Blood From Patients With Pancytopenia Pancytopenia | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 38 | 1986-04-30 | 2020-08-21 | |
| Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders antilymphocyte serum, nandrolone - Anemia, Aplastic, Hematologic Diseases | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1982-03-01 | 2013-11-26 |
Showing 20 of 21. Sign in to see all of them.
Anemia, Aplastic (13) · Bone Marrow Failure Disorders (6) · Hematologic Diseases (4) · Autoimmune Diseases (3) · Myelodysplastic Syndromes (3) · Neutropenia (3) · Thrombocytopenia (3) · Congenital Bone Marrow Failure Syndromes (2) · Fanconi Anemia (2) · Immunologic Deficiency Syndromes (2) · Leukocyte Disorders (2) · Leukopenia (2) · Primary Immunodeficiency Diseases (2) · Anemia, Hemolytic, Autoimmune (1)
Hemic and Lymphatic Diseases (21) · Cytopenia (20) · Bone Marrow Diseases (17) · Hematologic Diseases (17) · Anemia (15) · Bone Marrow Failure Disorders (12) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6) · Immune System Diseases (5) · Leukocyte Disorders (5) · Blood Platelet Disorders (4) · Genetic Diseases, Inborn (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Agranulocytosis (3) · Leukopenia (3)
eltrombopag (4) · Cyclosporine (3) · Antilymphocyte Serum (2) · Cyclophosphamide (2) · thymoglobulin (2) · Alemtuzumab (1) · Base Sequence (1) · Bone Marrow Transplantation (1) · Cyclosporins (1) · Influenza Vaccines (1) · Nandrolone (1) · ancestim (1) · fludarabine (1)
National Heart, Lung, and Blood Institute (NHLBI) (9) · Assiut University (3) · Novartis Pharmaceuticals (2) · Christopher Dvorak (1) · Dren Bio (1) · Medical University of Graz (1) · National Institute of Blood Disease Center, Pakistan (1) · National Institute of Dental and Craniofacial Research (NIDCR) (1) · Peter MacCallum Cancer Centre, Australia (1) · Shwachman-Diamond Syndrome Alliance Inc (1)
United States (12) · Japan (2) · Australia (1) · Austria (1) · Pakistan (1)
Danielle M Townsley, M.D. (3) · Neal S Young, M.D. (2) · Andre Larochelle, M.D. (1) · Christopher Dvorak, MD (1) · Neal Young (1) · Piers Blombery, MBBS(Hons) (1) · Wan-Jen Hong, MD (1)
PMID 34724566, PMID 29674506, PMID 29958797, PMID 25185712, PMID 26354756, PMID 27658437, PMID 29419434, PMID 31183813, PMID 33410523, PMID 33910334, PMID 34525188, PMID 37142543